首页> 美国卫生研究院文献>Molecular Genetics Genomic Medicine >A likely pathogenic variant putatively affecting splicing of PIGA identified in a multiple congenital anomalies hypotonia‐seizures syndrome 2 (MCAHS2) family pedigree via whole‐exome sequencing
【2h】

A likely pathogenic variant putatively affecting splicing of PIGA identified in a multiple congenital anomalies hypotonia‐seizures syndrome 2 (MCAHS2) family pedigree via whole‐exome sequencing

机译:通过全外显子测序确定了在多个先天性异常性低渗性癫痫综合征2(MCAHS2)家族谱系中确定的可能影响PIGA剪接的致病变异

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundGlycosylphosphatidylinositol (GPI) anchoring is a special type of protein posttranslational modification, by which proteins with diverse function are attached to cell membrane through a covalent linkage between the protein and the glycolipid. Phosphatidylinositol glycan anchor biosynthesis class A (PIGA) is a key enzyme in GPI anchor biosynthesis, somatic mutations or genetic variants of which have been associated with paroxysmal nocturnal hemoglobinuria (PNH), or PIGA deficiency, respectively. More than 10 PIGA pathogenic or likely pathogenic variants have been reported in a wide spectrum of clinical syndromes of PIGA deficiency, including multiple congenital anomalies hypotonia‐seizures syndrome 2 (MCAHS2).
机译:背景技术糖基磷脂酰肌醇(GPI)锚定是一种特殊类型的蛋白质翻译后修饰,通过这种修饰,具有多种功能的蛋白质通过蛋白质和糖脂之间的共价键连接到细胞膜上。磷脂酰肌醇聚糖锚定生物合成A类(PIGA)是GPI锚定生物合成中的关键酶,其体细胞突变或遗传变异分别与阵发性夜间血红蛋白尿(PNH)或PIGA缺乏有关。在广泛的PIGA缺乏症临床综合征中,已经报告了超过10种PIGA致病性或可能的致病性变体,包括多个先天性异常性低渗性癫痫综合征2(MCAHS2)。

著录项

相似文献

  • 外文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号